Is Ozempic a Glp 1

Yes, Ozempic (semaglutide) is a GLP-1 receptor agonist medication. GLP-1 stands for glucagon-like peptide-1, a hormone that regulates blood sugar and slows gastric emptying. Originally FDA-approved for type 2 diabetes management in 2017, Ozempic mimics this natural hormone by binding to GLP-1 receptors throughout the body. Clinical trials show semaglutide can reduce A1C levels by 1.5-2.0% and body weight by 10-15% in many patients. The medication is administered as a once-weekly subcutaneous injection and belongs to the same class of drugs as other GLP-1 agonists like liraglutide and dulaglutide.